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Intraluminal Interaction of Tissue and Stented CS Lead. Introduction: The aim of our investi-
gation was to examine the intraluminal interaction of the vascular tissue and the implanted coronary sinus
lead stabilized with stent on two human hearts removed before transplantation.
Methods and results: The coronary sinus lumen was sectioned under operational microscope and opened
carefully. The leads and stents were found separately positioned beside each other completely covered by
an intact intimal tissue layer. No sign of occluding proliferative tissue was observed.
Conclusion: Stent fixation technique and extraction of the CS lead in our cases did not have any particular
damaging effect on the vascular system. (J Cardiovasc Electrophysiol, Vol. pp. 1-3)
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Introduction
Cardiac resynchronization therapy (CRT) is an effective
nonpharmacological therapeutic method for the treatment of
selected patients with chronic heart failure associated with
wide QRS complex and mechanical dyssynchrony. Implan-
tation of the coronary sinus (CS) lead is still the technically
most challenging part of CRT, 5–9% of patients have dis-
lodgement or microdislodgements during the follow-up, re-
sulting in loss of resynchronization or inadvertent phrenic
nerve stimulation.1-4 The recently published MADIT CRT
trial showed that 7.5% of CS lead implantations were unsuc-
cessful5 and 5–10% of patients required re-operation during
the follow-up because of CS lead dysfunction.5-7 Stent im-
plantation may increase the stability of the lead position by
anchoring the CS electrode to the wall of the CS side branch.
A stable lead position may improve the implantation success
rate and decrease postoperative complications.8,9
The aim of our study was to examine the intraluminal tis-
sue reaction of coronary sinus induced by an implanted CS
lead, stabilized with a coronary stent on two surgically re-
moved hearts. The morphological vascular alterations of the
coronary sinus and the effects of the extraction of implanted
devices on the blood vessels were also investigated.
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Methods
Clinical Background
Patient No. 1 was a 58-year-old woman with a history of
serious chronic heart failure due to dilated cardiomyopathy
with left bundle branch block (native QRS width during atrial
fibrillation: 130 ms). A CRT-P and later an upgraded CRT-D
system implantations were performed to improve the pro-
gressively worsening functional cardiac state. Patient No. 2
was a 58-year-old man with a history of progressive chronic
heart failure due to dilated cardiomyopathy with left bundle
branch block (QRS width: 170 ms). The patient underwent
CRT-D implantation because of a documented nonsustained
ventricular tachycardia.
Both of the patients responded initially to CRT therapy and
then the clinical course was led by the continuous worsening
of the heart failure. They were scheduled to heart transplan-
tation formerly and the ICD backup was the choice of bridge
to transplant.
The coronary sinus leads were positioned into a lateral
side branch of CS. In both cases intraoperative dislodgement
occurred due to the unstable anatomical position of the CS
leads (Patient 1: Corox OTW UP 75, Biotronik; Patient 2:
Attain OTW 4193, Medtronic). Stent placement was used
to achieve effective pacing from the CS site and to prevent
lead dislodgement: a second guide wire was introduced into
the target vein over the same CS sheath, then the coronary
stent was positioned over this second guide wire introduced
into the CS side branch besides the lead body. The CS leads
were successfully stabilized with properly deployed coronary
stents (Patient 1: Micro Driver 2.5×8, Medtronic; Patient 2:
Trimaxx 3.0 × 11, Abbott Vascular). Stents were deployed
with a pressure of 10 atmospheres with a duration of 6 sec-
onds. The diameter of the stents was chosen according to the
diameter of the target CS side branch which was measured on
the CS venogram. Measurements after expanding the stent
showed appropriate left ventricular pacing parameters that
remained stable during the observation.
The leads functioned for 26 months (Patient 1) and
15 months (Patient 2) after implantation, when the patients
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Figure 1. Endothelial tissue proliferation around the coronary sinus lead
stabilized with a stent. A: Microscopic view after dissection of the vein, the
stent and the lead are positioned separately. B: Magnified image of distance
between the lead body and coronary stent after dissection of the vein. C:
The lead covered with a thin tissue layer beyond the coronary ostium. D: The
cross-sectional view of the tissue tube after the lead extraction, the struts of
the stent are covered with a tissue layer.
Figure 2. Recanalization within the stent lumen (Blue stars: details of the
location of removed stent struts. Red circles: the area of chronic inflam-
maory cells [mainly lymphocytes] in foci located in the vicinity of the stent
struts. Blue arrows: recanalization within the stent lumen, cellular blood
components [RBC and WBC] in the lumen of small vessels).
underwent successful heart transplantation due to worsen-
ing heart failure. The heart was removed together with the
lead stabilized by the stent and it was immersed in a formalin
solution for fixation and further morphological examination.
Method of Investigation
The coronary sinus was dissected and opened along its
long axis with extraordinary care to protect the delicate struc-
ture of the CS and implanted devices. Stereo Microscope
(Nikon, SMZ2T) and Olympus Camedia 5500 digital cam-
era were used to record the procedure. After the removal
of the covering tissue layer, the CS lead and stent positions
were recorded. Under visual microscopic control the CS leads
Figure 3. Damages of the explanted coronary sinus lead stabilized with
a stent. The deepest injury is visible as well as the stented area, which is
smooth, the free surface is rugged.
were manually extracted. Optical analysis was used to further
examine the stents and coronary sinus after extraction.
A coronary sinus section was prepared for histological
examination hematoxylin-eosin staining under Zeiss micro-
scope and the pictures were recorded by a digital camera.
The analysis of coronary sinus lead surface, detection
of insulation damages and verification of electronic and
functional integrity with microscopy and impedance
measurement were performed using previously published
methodology.10,11
Results
The coronary sinus leads and stents were completely cov-
ered with an intact intimal tissue layer. In both cases the
lead and the stent was found separately positioned besides
each other, without any morphological sign of proliferative
or scarring tissue reaction (Fig. 1). The thickness of the tissue
layer between the lead and the stent was 370 µm at the lead
body and it was 110 µm at the tip area in Patient 1. The tissue
layer in Patient 2 was 96 µm thick between the lead and the
coronary stent.
The coronary sinus leads were gently and easily extracted
manually without any particular physical effort. During the
removal procedure of these 2 cases neither stent deformation
nor any noticeable tissue damage was observed in the coro-
nary sinus. The tissue reaction formed a tube-like coverage
around the lead that was intact after the gentle extraction and
no injury was found on the inner surface of the tissue layer.
Histological examination (Fig. 2) of the coronary sinus
confirmed recanalization of the coronary stent lumen. Ac-
cumulation of chronic inflammatory cells (mainly lympho-
cytes) was visible in the internal lumen of coronary stent.
Recanalization was recognized with formation of small ves-
sels and cellular blood components (RBC and WBC).
The results of impedance measurements of the explanted
did not show measurable electronic leakage during the insu-
lation testing.
Only one deeper injury (Fig. 3) was detected on the surface
of the Corox OTW lead, close to the tip, where the stent was
placed. The surface damage had a dimension of 279 (width)
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× 250 (length)× 34 (depth) µm, which did not penetrate the
thickness of the insulation. Minor, 3–5 µm deep, superficial
surface injuries were found on the Attain OTW lead in the
stented area. No injury was observed that might have resulted
from the lead extraction.
Discussion
Pacemaker electrode stabilization with coronary stent
placement can be a useful technique to maintain an opti-
mal and stable position of implanted coronary sinus lead to
prevent dislodgements or microdislodgements.12-15
In our case reports we examined the intraluminal physical
and histological changes around the lead and the stent in the
coronary sinus. We assume that the deeper damage and minor
surface injuries at the stented region might be the result of the
continuous friction due to the heart motion but not related to
the lead extraction. The tissue layer in between the stent and
the lead probably prevented injuries during extraction. Based
on our findings it is not possible to determine how much the
implantation process did contribute to the changes observed
at the end of a long follow-up.
In our cases, the stent fixation technique did not have any
particular damaging effect on the local vascular system. The
images show an excellent internal protecting tissue layer with
tube formation around the lead. The stent is rather deeply im-
pacted into the inner vascular wall covered with a tissue layer.
No traces of active thrombotic process, developing scars, tis-
sue proliferation or chronic total occlusion were found. We
could not reveal total lumen loss in the affected coronary si-
nus region that might be the result of some maintained blood
flow through the implanted stent after the implantation. The
histological examination proved evidence of endothelization
process that likely is a complex tissue regenerating procedure
as the result of a delicate interaction of blood components
and vessel wall.
Mechanical support of stent for the fixation of lead is prob-
ably beneficial in the early postinterventional period until the
intravascular endothelial reaction is completed, developing
a tube-like tissue structure that keeps the lead in position.
However, these observations are based only on the exami-
nation of two samples, therefore, further studies and in situ
observations are required for a better understanding of the
lead-stent-vessel intravascular interaction.
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